150 related articles for article (PubMed ID: 16083746)
21. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE.
Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR;
J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425
[TBL] [Abstract][Full Text] [Related]
22. State-of-the-art: prostate LDR brachytherapy.
Voulgaris S; Nobes JP; Laing RW; Langley SE
Prostate Cancer Prostatic Dis; 2008; 11(3):237-40. PubMed ID: 18364676
[TBL] [Abstract][Full Text] [Related]
23. Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at risk.
Crook JM; Potters L; Stock RG; Zelefsky MJ
Brachytherapy; 2005; 4(3):186-94. PubMed ID: 16182218
[TBL] [Abstract][Full Text] [Related]
24. Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
Copeland LA; Elshaikh MA; Jackson J; Penner LA; Underwood W
Cancer; 2005 Oct; 104(7):1372-80. PubMed ID: 16118801
[TBL] [Abstract][Full Text] [Related]
25. Rectourethral fistula after combination radiotherapy for prostate cancer.
Marguet C; Raj GV; Brashears JH; Anscher MS; Ludwig K; Mouraviev V; Robertson CN; Polascik TJ
Urology; 2007 May; 69(5):898-901. PubMed ID: 17482930
[TBL] [Abstract][Full Text] [Related]
26. [Curative radiotherapy of cancer of the prostate].
Gérard JP; Romestaing P; Montbarbon X
Pathol Biol (Paris); 1989 Feb; 37(2):116-7. PubMed ID: 2652057
[No Abstract] [Full Text] [Related]
27. The risk and prophylactic management of bladder cancer after various forms of radiotherapy.
Shirodkar SP; Kishore TA; Soloway MS
Curr Opin Urol; 2009 Sep; 19(5):500-3. PubMed ID: 19553822
[TBL] [Abstract][Full Text] [Related]
28. Risk of second cancer following radiotherapy for prostate cancer: a population-based analysis.
Hegemann NS; Schlesinger-Raab A; Ganswindt U; Hörl C; Combs SE; Hölzel D; Gschwend JE; Stief C; Belka C; Engel J
Radiat Oncol; 2017 Jan; 12(1):2. PubMed ID: 28049538
[TBL] [Abstract][Full Text] [Related]
29. Temporal relationship between prostate brachytherapy and the diagnosis of colorectal cancer.
Gutman SA; Merrick GS; Butler WM; Wallner KE; Allen ZA; Galbreath RW; Adamovich E
Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):48-55. PubMed ID: 16750312
[TBL] [Abstract][Full Text] [Related]
30. Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment.
Bhatnagar V; Stewart ST; Huynh V; Jorgensen G; Kaplan RM
Prostate Cancer Prostatic Dis; 2006; 9(2):136-46. PubMed ID: 16402091
[TBL] [Abstract][Full Text] [Related]
31. Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.
Zelefsky MJ; Nedelka MA; Arican ZL; Yamada Y; Cohen GN; Shippy AM; Park JJ; Zaider M
Brachytherapy; 2008; 7(1):1-6. PubMed ID: 18299108
[TBL] [Abstract][Full Text] [Related]
32. [Advancement of treatment for prostate cancer].
Hara I
Gan To Kagaku Ryoho; 2006 Feb; 33(2):178-82. PubMed ID: 16484852
[TBL] [Abstract][Full Text] [Related]
33. Second primary cancer risk of radiation therapy after radical prostatectomy for prostate cancer: an analysis of SEER data.
Abdel-Wahab M; Reis IM; Wu J; Duncan R
Urology; 2009 Oct; 74(4):866-71. PubMed ID: 19628258
[TBL] [Abstract][Full Text] [Related]
34. Re: Bladder cancer risk following primary and adjuvant external beam radiation for prostate cancer.
Brenner DJ; Hall EJ
J Urol; 2006 Feb; 175(2):788-9; author reply 789. PubMed ID: 16407052
[No Abstract] [Full Text] [Related]
35. Predictive factors for acute and late urinary toxicity after permanent prostate brachytherapy: long-term outcome in 712 consecutive patients.
Keyes M; Miller S; Moravan V; Pickles T; McKenzie M; Pai H; Liu M; Kwan W; Agranovich A; Spadinger I; Lapointe V; Halperin R; Morris WJ
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1023-32. PubMed ID: 19111402
[TBL] [Abstract][Full Text] [Related]
36. Radioactive "seed" implants may rival surgery for low-risk prostate cancer patients.
Hede K
J Natl Cancer Inst; 2007 Oct; 99(20):1507-9. PubMed ID: 17925531
[No Abstract] [Full Text] [Related]
37. [Second neoplasms after percutaneous radiotherapy].
Haidl F; Pfister D; Semrau R; Heidenreich A
Urologe A; 2017 Mar; 56(3):342-350. PubMed ID: 27844130
[TBL] [Abstract][Full Text] [Related]
38. Second cancers in children treated with modern radiotherapy techniques.
Schneider U; Lomax A; Timmermann B
Radiother Oncol; 2008 Nov; 89(2):135-40. PubMed ID: 18707783
[TBL] [Abstract][Full Text] [Related]
39. Stat bite: Lifetime risk of being diagnosed with cancer.
J Natl Cancer Inst; 2003 Dec; 95(23):1745. PubMed ID: 14652235
[No Abstract] [Full Text] [Related]
40. Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.
Demanes DJ; Brandt D; Schour L; Hill DR
Am J Clin Oncol; 2009 Aug; 32(4):342-7. PubMed ID: 19398902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
